Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients

The role of natural killer (NK) cells in organ transplantation is controversial. This study aims to decipher their role in kidney transplant tolerance in humans. Previous studies highlighted several modulated genes involved in NK cell biology in blood from spontaneously operationally tolerant patien...

Full description

Bibliographic Details
Main Authors: Emilie Dugast, Gaëlle David, Romain Oger, Richard Danger, Jean-Paul Judor, Katia Gagne, Mélanie Chesneau, Nicolas Degauque, Jean-Paul Soulillou, Pascale Paul, Christophe Picard, Pierrick Guerif, Sophie Conchon, Magali Giral, Nadine Gervois, Christelle Retière, Sophie Brouard
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.01721/full
id doaj-d9c8d9fa0f8042abb15d408f7485a62a
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Emilie Dugast
Emilie Dugast
Gaëlle David
Gaëlle David
Romain Oger
Richard Danger
Richard Danger
Jean-Paul Judor
Jean-Paul Judor
Katia Gagne
Katia Gagne
Katia Gagne
Mélanie Chesneau
Mélanie Chesneau
Nicolas Degauque
Nicolas Degauque
Jean-Paul Soulillou
Jean-Paul Soulillou
Pascale Paul
Christophe Picard
Christophe Picard
Pierrick Guerif
Pierrick Guerif
Pierrick Guerif
Sophie Conchon
Sophie Conchon
Magali Giral
Magali Giral
Magali Giral
Nadine Gervois
Christelle Retière
Christelle Retière
Sophie Brouard
Sophie Brouard
spellingShingle Emilie Dugast
Emilie Dugast
Gaëlle David
Gaëlle David
Romain Oger
Richard Danger
Richard Danger
Jean-Paul Judor
Jean-Paul Judor
Katia Gagne
Katia Gagne
Katia Gagne
Mélanie Chesneau
Mélanie Chesneau
Nicolas Degauque
Nicolas Degauque
Jean-Paul Soulillou
Jean-Paul Soulillou
Pascale Paul
Christophe Picard
Christophe Picard
Pierrick Guerif
Pierrick Guerif
Pierrick Guerif
Sophie Conchon
Sophie Conchon
Magali Giral
Magali Giral
Magali Giral
Nadine Gervois
Christelle Retière
Christelle Retière
Sophie Brouard
Sophie Brouard
Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
Frontiers in Immunology
natural killer
cytotoxicity
tolerance
kidney
transplantation
author_facet Emilie Dugast
Emilie Dugast
Gaëlle David
Gaëlle David
Romain Oger
Richard Danger
Richard Danger
Jean-Paul Judor
Jean-Paul Judor
Katia Gagne
Katia Gagne
Katia Gagne
Mélanie Chesneau
Mélanie Chesneau
Nicolas Degauque
Nicolas Degauque
Jean-Paul Soulillou
Jean-Paul Soulillou
Pascale Paul
Christophe Picard
Christophe Picard
Pierrick Guerif
Pierrick Guerif
Pierrick Guerif
Sophie Conchon
Sophie Conchon
Magali Giral
Magali Giral
Magali Giral
Nadine Gervois
Christelle Retière
Christelle Retière
Sophie Brouard
Sophie Brouard
author_sort Emilie Dugast
title Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
title_short Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
title_full Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
title_fullStr Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
title_full_unstemmed Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
title_sort broad impairment of natural killer cells from operationally tolerant kidney transplanted patients
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2017-12-01
description The role of natural killer (NK) cells in organ transplantation is controversial. This study aims to decipher their role in kidney transplant tolerance in humans. Previous studies highlighted several modulated genes involved in NK cell biology in blood from spontaneously operationally tolerant patients (TOLs; drug-free kidney-transplanted recipients with stable graft function). We performed a phenotypic, functional, and genetic characterization of NK cells from these patients compared to kidney-transplanted patients with stable graft function under immunosuppression and healthy volunteers (HVs). Both operationally TOLs and stable patients harbored defective expression of the NKp46 activator receptor and lytic molecules perforin and granzyme compared to HVs. Surprisingly, NK cells from operationally TOLs also displayed decreased expression of the CD16 activating marker (in the CD56Dim NK cell subset). This decrease was associated with impairment of their functional capacities upon stimulation, as shown by lower interferon gamma (IFNγ) production and CD107a membranous expression in a reverse antibody-dependent cellular cytotoxicity (ADCC) assay, spontaneous lysis assays, and lower target cell lysis in the 51Cr release assay compared to HVs. Conversely, despite impaired K562 cell lysis in the 51Cr release assay, patients with stable graft function harbored a normal reverse ADCC and even increased amounts of IFNγ+ NK cells in the spontaneous lysis assay. Altogether, the strong impairment of the phenotype and functional cytotoxic capacities of NK cells in operationally TOLs may accord with the establishment of a pro-tolerogenic environment, despite remaining highly activated after transplantation in patients with stable graft function.
topic natural killer
cytotoxicity
tolerance
kidney
transplantation
url http://journal.frontiersin.org/article/10.3389/fimmu.2017.01721/full
work_keys_str_mv AT emiliedugast broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT emiliedugast broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT gaelledavid broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT gaelledavid broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT romainoger broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT richarddanger broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT richarddanger broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT jeanpauljudor broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT jeanpauljudor broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT katiagagne broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT katiagagne broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT katiagagne broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT melaniechesneau broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT melaniechesneau broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT nicolasdegauque broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT nicolasdegauque broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT jeanpaulsoulillou broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT jeanpaulsoulillou broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT pascalepaul broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT christophepicard broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT christophepicard broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT pierrickguerif broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT pierrickguerif broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT pierrickguerif broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT sophieconchon broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT sophieconchon broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT magaligiral broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT magaligiral broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT magaligiral broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT nadinegervois broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT christelleretiere broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT christelleretiere broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT sophiebrouard broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
AT sophiebrouard broadimpairmentofnaturalkillercellsfromoperationallytolerantkidneytransplantedpatients
_version_ 1725246359897899008
spelling doaj-d9c8d9fa0f8042abb15d408f7485a62a2020-11-25T00:50:49ZengFrontiers Media S.A.Frontiers in Immunology1664-32242017-12-01810.3389/fimmu.2017.01721312035Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted PatientsEmilie Dugast0Emilie Dugast1Gaëlle David2Gaëlle David3Romain Oger4Richard Danger5Richard Danger6Jean-Paul Judor7Jean-Paul Judor8Katia Gagne9Katia Gagne10Katia Gagne11Mélanie Chesneau12Mélanie Chesneau13Nicolas Degauque14Nicolas Degauque15Jean-Paul Soulillou16Jean-Paul Soulillou17Pascale Paul18Christophe Picard19Christophe Picard20Pierrick Guerif21Pierrick Guerif22Pierrick Guerif23Sophie Conchon24Sophie Conchon25Magali Giral26Magali Giral27Magali Giral28Nadine Gervois29Christelle Retière30Christelle Retière31Sophie Brouard32Sophie Brouard33Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceEtablissement Français du sang, Nantes, FranceCRCINA, INSERM, Université d’Angers, Université de Nantes, Nantes, FranceCRCINA, INSERM, Université d’Angers, Université de Nantes, Nantes, FranceCentre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceCentre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceEtablissement Français du sang, Nantes, FranceCRCINA, INSERM, Université d’Angers, Université de Nantes, Nantes, FranceLabEx Transplantex, Université de Strasbourg, FranceCentre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceCentre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceCentre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceNephrology Dialysis Renal Transplantation Center, Assistance Publique des Hôpitaux de Marseille, Hospital de la Conception, UMR 1076, Vascular Research Center of Marseille, INSERM, Aix-Marseille University, Marseille, FranceÉtablissement Français du Sang Alpes Méditerranée, Marseille, FranceADES UMR 7268, CNRS, EFS, Aix-Marseille Université, Marseille, FranceCentre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceCIC Biotherapy, CHU Nantes, Nantes, FranceCentre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceCentre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceCIC Biotherapy, CHU Nantes, Nantes, FranceCRCINA, INSERM, Université d’Angers, Université de Nantes, Nantes, FranceEtablissement Français du sang, Nantes, FranceCRCINA, INSERM, Université d’Angers, Université de Nantes, Nantes, FranceCentre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, FranceInstitut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, FranceThe role of natural killer (NK) cells in organ transplantation is controversial. This study aims to decipher their role in kidney transplant tolerance in humans. Previous studies highlighted several modulated genes involved in NK cell biology in blood from spontaneously operationally tolerant patients (TOLs; drug-free kidney-transplanted recipients with stable graft function). We performed a phenotypic, functional, and genetic characterization of NK cells from these patients compared to kidney-transplanted patients with stable graft function under immunosuppression and healthy volunteers (HVs). Both operationally TOLs and stable patients harbored defective expression of the NKp46 activator receptor and lytic molecules perforin and granzyme compared to HVs. Surprisingly, NK cells from operationally TOLs also displayed decreased expression of the CD16 activating marker (in the CD56Dim NK cell subset). This decrease was associated with impairment of their functional capacities upon stimulation, as shown by lower interferon gamma (IFNγ) production and CD107a membranous expression in a reverse antibody-dependent cellular cytotoxicity (ADCC) assay, spontaneous lysis assays, and lower target cell lysis in the 51Cr release assay compared to HVs. Conversely, despite impaired K562 cell lysis in the 51Cr release assay, patients with stable graft function harbored a normal reverse ADCC and even increased amounts of IFNγ+ NK cells in the spontaneous lysis assay. Altogether, the strong impairment of the phenotype and functional cytotoxic capacities of NK cells in operationally TOLs may accord with the establishment of a pro-tolerogenic environment, despite remaining highly activated after transplantation in patients with stable graft function.http://journal.frontiersin.org/article/10.3389/fimmu.2017.01721/fullnatural killercytotoxicitytolerancekidneytransplantation